Visionary concerning regulatory information management, considering the right-first-time creation of information and documentation (content) and the ability to see the scientific content in context of use. Content concerns regulatory-, chemical/pharmaceutical-, nonclinical- and clinical information justifying the consistently produced high quality drugs with a favourable benefit-risk ratio for a clearly defined patient population when used in accordance with the prescribing information.